Oncology Medical News about renal cell carcinoma

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Analysis of PTEN and HIF-1[alpha] and correlation with efficacy in patients with advanced renal cell carcinoma treated with temsirolimus versus interferon-[alpha]
Cancer, 06/16/09

Figlin RA et al. - The baseline status of the molecular markers PTEN and HIF1 alpha did not correlate with efficacy in renal cell carcinoma patients treated with temsirolimus versus IFN. Patients demonstrated OS and progression-free survival benefit when treated with temsirolimus regardless of PTEN and HIF1 alpha status.

Exclusive Author Commentary
Robert A. Figlin, 06/16/09

Although this study did not demonstrate a correlation with response and survival for the biomarkers tested, it remains a high priority for all trials in renal cell carcinoma to identify and test the validity of a biomarker to predict biologic behavior.

<< Previous
Rational approach to implementation of prostate cancer antigen 3...

Next >>
Secondary sarcomas after radiotherapy for breast cancer